Leuko Labs

Year 2019
Area Devices and Materials, Healthcare and Medical

Leuko Labs’ technology monitors white blood cell levels non-invasively, helping immunosuppressed and chemotherapy patients avoid infections and febrile neutropenia.

Shining light into the skin surrounding the fingernail, Leuko’s device images the blood cells flowing through superficial capillaries to determine if white cell levels are dangerously low. There is no need to extract blood. Millions of immunosuppressed patients can now be tested more frequently, improving their quality of life and clinical outcomes.

""

A new way to spot life-threatening infections in cancer patients

Leuko is giving doctors a noninvasive way to monitor health during chemotherapy — no blood tests needed

Non-invasive white cell count prototype

The company is a spin-out from the 2016 project, Non-invasive white cell count prototype.